Opioid use disorder and clinical outcomes following percutaneous coronary intervention for acute coronary syndromes.

Authors

Ali Awad, Mohammad Hamza, Asa Smith-Villegas, Aiden Tang, Prit Patel, Tarun Bomma, Ali Eidy, Vaishnavi Sirekulam, Mohammad Akkawi, Jawad Basit, Hafeezuddin Ahmed, Aziz Alkatib, M Chadi Alraies

Published in

Journal of thrombosis and thrombolysis. Jun 30, 2026. Epub Jun 30, 2026.

Abstract

Opioid use disorder (OUD) is increasingly encountered among patients presenting with acute coronary syndromes (ACS), yet its impact on outcomes following percutaneous coronary intervention (PCI) remains unclear. We conducted a single-center retrospective cohort study of 5,875 patients undergoing PCI for ACS between 2012 and 2019. Patients were stratified by documented OUD identified using ICD-9 and ICD-10 codes. In-hospital, 30-day, 6-month, and 1-year Outcomes were assessed using multivariable logistic regression, propensity score matching, and time-to-event analyses. Compared with non-OUD patients, those with OUD were more likely to be African American, active smokers, and to have chronic obstructive pulmonary disease, but had lower rates of diabetes. After adjustment, OUD was associated with significantly higher odds of LifeVest prescription during the index hospitalization (adjusted OR 9.94, 95% CI 3.13-31.55). At 30 days, OUD was independently associated with higher risks of any-lesion coronary reintervention (adjusted OR 2.90, 95% CI 1.49-5.66) and same-lesion reintervention (adjusted OR 4.76, 95% CI 1.93-11.77). At 1 year, OUD showed a trend toward higher congestive heart failure readmission (adjusted OR 3.05, 95% CI 0.91-10.28), without significant associations with recurrent ACS or all-cause mortality. Among patients undergoing PCI for ACS, OUD is associated with increased early coronary reintervention and greater likelihood of LifeVest prescription, without increased mortality. These findings highlight a vulnerable population that may benefit from enhanced post-PCI monitoring and multidisciplinary care.

PMID:
42377681
Bibliographic data and abstract were imported from PubMed on 30 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.